UBIDECARENONE

Not available outside of the UK & Ireland.

Analysis Note

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

Application

Ubidecarenone may be used as a pharmaceutical reference standard for the quantification of the analyte in combined pharmaceutical dosage form using reversed-phase high-performance liquid chromatography technique.

Footnote

To see an example of a Certificate of Analysis for this material enter LRAB0979 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

General description

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Ubidecarenone is a dietary supplement, and a cardiovascular agent employed in the treatment of angina pectoris and congestive cardiac failure. Its mode of action involves the improvement of cardiac output by increasing the contractive force of the heart through positive inotropic action.

Other Notes

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.